MARATTO

article · Nigerian Journal of Natural Products and Medicine

Selected medicinal plants exhibit selective cytotoxicity against breast (MCF-7) and rhabdomyosarcoma (RD) cancer cell lines

2025Open accessUniversity of Buea

Abstract

Cancer is one of the most frightening diseases threatening the health of mankind, with poor prognosis and treatment. Current cancertreatment options, though costly to develop, have not met expectations largely due to issues like recurrence, drug resistance, pooraccessibility, and serious side effects. This necessitates the search for new potent chemotherapeutic agents with high selectivity.Therefore, Phytochemical constituents and cytotoxic potentials of four selected medicinal plants were investigated. In vitro cytotoxic activity of the selected plant extracts using MTT (3(4,5-dimethylthiazol-2-yl)-2-diphenyltetrazolium bromide) colorimetric assay was carried out against human breast cancer (MCF-7) and Rhabdomyosarcoma (RD) cell lines. The selective index (SI) of the extracts was also determined using the Vero cell line. Indigofera nummularriifolia (INW) exhibited the highest inhibition on the growth of MCF-7 (IC50 = 1.22 µg/mL) and RD (IC50 = 6.51 µg/mL) cell lines as compared with the standard reference drug, vincristine with IC50 = 0.25 and 2.89 µg/mL on MCF-7 and RD cancer cell lines, respectively. Determination of SI 50 using the Vero cell line indicated that INW displayed a relatively high degree of selectivity against the cancer cells under investigation. These plants especially I. nummularriifolia exhibited cytotoxic effects and thus could contribute to anticancer drug discovery and many other disease conditions due to their phytoconstituents.

Research topics

  • Bioactive natural compounds
  • Flavonoids in Medical Research
  • Phytochemicals and Medicinal Plants

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4314/njnpm.v28i2.1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.